PharmaEssentia - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsPharmaEssentia

PharmaEssentia

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Besremi	Ropeginterferon alfa-2b	2021-11-12		Polycythemia vera

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

Calcium carbonate

,

,

acquired immunodeficiency syndrome

,

,

,

hyperparathyroidism

,

secondary hyperparathyroidism

Antithrombin iii

healthy volunteers/patients

,

pharmacokinetics

,

biological availability

,

renal insufficiency

,

chronic kidney failure

,

kidney diseases

,

,

chronic hepatitis b

,

,

chronic hepatitis

,

,

,

,

therapeutic equivalency

,

bariatric surgery

,

cardiovascular diseases

,

thromboembolism

,

venous thromboembolism

,

acute coronary syndrome

,

,

,

,

,

,

,

myocardial infarction

,

myocardial ischemia

,

,

knee osteoarthritis

,

,

,

,

prostatic neoplasms

,

,

percutaneous coronary intervention

,

unstable angina

,

hip osteoarthritis

,

,

coronavirus infections

,

,

respiratory insufficiency

,

communicable diseases

,

rheumatic diseases

,

collagen diseases

,

coronary disease

,

pancreatic neoplasms

,

intracranial arteriosclerosis

,

arteriosclerosis

,

kidney transplantation

,

transcatheter aortic valve replacement

,

,

,

,

psoriatic arthritis

,

atrial fibrillation

,

,

,

venous thrombosis

,

pulmonary embolism

,

coronary artery disease

,

peripheral arterial disease

,

,

peripheral vascular diseases

,

,

disease progression

,

,

,

congenital heart defects

,

,

fontan procedure

,

replacement arthroplasty knee

,

replacement arthroplasty hip

neoplasm metastasis

,

,

,

acquired immunodeficiency syndrome

,

,

immunologic deficiency syndromes

,

,

pancreatic neoplasms

,

,

non-small-cell lung carcinoma

,

squamous cell carcinoma of head and neck

,

squamous cell carcinoma

,

esophageal squamous cell carcinoma

,

,

,

chronic hepatitis b

,

,

chronic hepatitis

,

Albinterferon alfa-2b

kidney neoplasms

,

communicable diseases

,

,

renal cell carcinoma

,

,

brain neoplasms

,

gastrointestinal stromal tumors

,

cholangiocarcinoma

,

primary myelofibrosis

,

,

,

,

hereditary hemorrhagic telangiectasia

,

,

pancreatic neoplasms

,

,

,

,

bcr-abl positive chronic myelogenous leukemia

,

,

myeloid leukemia

,

acquired immunodeficiency syndrome

,

,

,

,

,

neoadjuvant therapy

,

hepatocellular carcinoma

,

liver neoplasms

,

chronic hepatitis d

,

,

liver transplantation

,

,

depressive disorder

,

neoplasm metastasis

,

disease progression

,

,

,

,

chronic hepatitis c

,

chronic hepatitis

,

,

liver cirrhosis

,

,

chronic hepatitis b

,

,

,

,

chronic kidney failure

,

kidney diseases

,

,

insulin resistance

,

,

substance-related disorders

,

intravenous substance abuse

,

,

cutaneous malignant melanoma

,

non-hodgkin lymphoma

,

,

follicular lymphoma

chronic hepatitis

,

,

chronic hepatitis b

,

,

,

,

herpesviridae infections

,

healthy volunteers/patients

,

chronic hepatitis d

,

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use